Carmen A Pfortmueller1, Edith Fleischmann2. 1. Clinic for General Anesthesiology, Intensive Care and Pain Management, Medical University of Vienna, Vienna, Austria. Electronic address: cpfortmueller@gmail.com. 2. Clinic for General Anesthesiology, Intensive Care and Pain Management, Medical University of Vienna, Vienna, Austria. Electronic address: edith.fleischmann@meduniwien.ac.at.
Abstract
INTRODUCTION: The concept of fluid resuscitation with balanced solutions containing acetate is relatively new. The knowledge about acetate mostly originates from nephrological research, as acetate was primarily used as a dialysis buffer where much higher doses of acetate are infused. The aim of this review is to give an overview of the advantages and disadvantages of an acetate-buffered crystalloid fluid when compared with other crystalloid infusates. METHODS: We report trials with the primary object of comparing an acetate-buffered infusion solute to another crystalloid infusate. A systematic literature search of MEDLINE and the Cochrane Controlled Clinical trials register was conducted to identify suitable studies. RESULTS: The search strategy used produced 1205 potential titles. After eliminating doubles, 312 titles and abstracts were screened, and 31 references were retrieved for full-text analysis. A total of 27 scientific studies were included in the study. CONCLUSION: Acetate-buffered crystalloid solutes do have a favorable influence on microcirculation. To what extent the acetate-buffered crystalloids influence kidney function is controversially discussed and not yet clear. Metabolic alkalosis did not occur in a single study in humans after an acetate-buffered infusate; potassium levels stayed stable in all studies. Cardiac output and contractility seem to be positively influenced; nonetheless, data on maintenance of a target blood pressure remain inconclusive. Whether acetate-buffered crystalloid fluids lead to lower rates of acute kidney injury and increased survival when compared with normal saline is yet unclear and may depend on the amount of fluid administered.
INTRODUCTION: The concept of fluid resuscitation with balanced solutions containing acetate is relatively new. The knowledge about acetate mostly originates from nephrological research, as acetate was primarily used as a dialysis buffer where much higher doses of acetate are infused. The aim of this review is to give an overview of the advantages and disadvantages of an acetate-buffered crystalloid fluid when compared with other crystalloid infusates. METHODS: We report trials with the primary object of comparing an acetate-buffered infusion solute to another crystalloid infusate. A systematic literature search of MEDLINE and the Cochrane Controlled Clinical trials register was conducted to identify suitable studies. RESULTS: The search strategy used produced 1205 potential titles. After eliminating doubles, 312 titles and abstracts were screened, and 31 references were retrieved for full-text analysis. A total of 27 scientific studies were included in the study. CONCLUSION:Acetate-buffered crystalloid solutes do have a favorable influence on microcirculation. To what extent the acetate-buffered crystalloids influence kidney function is controversially discussed and not yet clear. Metabolic alkalosis did not occur in a single study in humans after an acetate-buffered infusate; potassium levels stayed stable in all studies. Cardiac output and contractility seem to be positively influenced; nonetheless, data on maintenance of a target blood pressure remain inconclusive. Whether acetate-buffered crystalloid fluids lead to lower rates of acute kidney injury and increased survival when compared with normal saline is yet unclear and may depend on the amount of fluid administered.
Authors: Neil Blumberg; Jill M Cholette; Anthony P Pietropaoli; Richard Phipps; Sherry L Spinelli; Michael P Eaton; Suzie A Noronha; Jerard Seghatchian; Joanna M Heal; Majed A Refaai Journal: Transfus Apher Sci Date: 2018-02-21 Impact factor: 1.764
Authors: Kush N Shah; Parth N Shah; Andrew R Mullen; Qingquan Chen; Marie R Southerland; Bhagath Chirra; Ralph J DeBerardinis; Carolyn L Cannon Journal: Toxicol Lett Date: 2020-07-10 Impact factor: 4.372
Authors: Ryan A Duffy; Mathab B Foroozesh; Robert D Loflin; Susanti R Ie; Bradley L Icard; Allison N Tegge; Jonathan R Nogueira; Damon R Kuehl; Dan C Smith; Anthony L Loschner Journal: J Intensive Care Soc Date: 2018-07-05
Authors: Carmen Andrea Pfortmueller; Dominik Uehlinger; Stephan von Haehling; Joerg Christian Schefold Journal: Intensive Care Med Exp Date: 2018-04-13
Authors: Carmen A Pfortmueller; Livia Faeh; Martin Müller; Balthasar Eberle; Hansjörg Jenni; Björn Zante; Josef Prazak; Lars Englberger; Jukka Takala; Stephan M Jakob Journal: Crit Care Date: 2019-05-06 Impact factor: 9.097
Authors: Manu L N G Malbrain; Thomas Langer; Djillali Annane; Luciano Gattinoni; Paul Elbers; Robert G Hahn; Inneke De Laet; Andrea Minini; Adrian Wong; Can Ince; David Muckart; Monty Mythen; Pietro Caironi; Niels Van Regenmortel Journal: Ann Intensive Care Date: 2020-05-24 Impact factor: 6.925